{"id":284174,"date":"2018-10-31T01:35:15","date_gmt":"2018-10-31T01:35:15","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=284174"},"modified":"2018-10-31T01:35:15","modified_gmt":"2018-10-31T01:35:15","slug":"nk-cell-therapy-market-2018-global-share-trend-segmentation-and-forecast-to-2025","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/nk-cell-therapy-market-2018-global-share-trend-segmentation-and-forecast-to-2025_284174.html","title":{"rendered":"NK Cell Therapy Market 2018 Global Share, Trend, Segmentation and Forecast to 2025"},"content":{"rendered":"<div style=\" width:250px; padding:8px 10px 10px 10px; float:right;\"><a href=\"https:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2018\/10\/1540963658.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"image\" src=\"https:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2018\/10\/1540963658.jpeg\" alt=\"\" width=\"225\" height=\"\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\" style=\" font-weight:bold; font-style:italic;\">\n<div>&#8220;\\&#8221;NK Cell Therapy Market\\&#8221;&#8221;<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">Wiseguyreports.Com Added New Market Research Report On -\u201cGlobal NK Cell Therapy Market 2018 Top Key Players, Production , Growth and Future Demand Forecast to 2025  \u201d.<\/div>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Global NK Cell Therapy <\/strong><strong>Market<\/strong><\/p>\n<p><strong>WiseGuyRerports.com Presents &ldquo;Global NK Cell Therapy Market Insights, Forecast to 2025&rdquo; New Document to its Studies Database. The Report Contain 119 Pages With Detailed Analysis.<\/strong><\/p>\n<p><strong>Description<\/strong><\/p>\n<p>This report studies the global market size of NK Cell Therapy in key regions like North America, Europe, Asia Pacific, Central &amp; South America and Middle East &amp; Africa, focuses on the consumption of NK Cell Therapy in these regions.&nbsp;<\/p>\n<p>This research report categorizes the global NK Cell Therapy market by players\/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter&#8217;s Five Forces Analysis.<\/p>\n<p>In 2017, the global NK Cell Therapy market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the NK Cell Therapy market based on company, product type, application and key regions.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Get sample Report @ <\/strong><a rel=\"nofollow\" href=\"https:\/\/www.wiseguyreports.com\/sample-request\/3444216-global-nk-cell-therapy-market-insights-forecast-to-2025\"><strong>https:\/\/www.wiseguyreports.com\/sample-request\/3444216-global-nk-cell-therapy-market-insights-forecast-to-2025<\/strong><\/a><\/p>\n<p>&nbsp;<\/p>\n<p>The various contributors involved in the value chain of NK Cell Therapy include manufacturers, suppliers, distributors, intermediaries, and customers. The <strong>key manufacturers<\/strong> in the NK Cell Therapy include&nbsp;<br \/><strong>Chipscreen Biosciences (China)&nbsp;<br \/>Affimed NV (Netherlands)&nbsp;<br \/>Altor BioScience Corporation (USA)&nbsp;<br \/>Innate Pharma SA (France)&nbsp;<br \/>Takeda Pharmaceutical (Japan)&nbsp;<br \/>Sorrento Therapeutics Inc. (USA)&nbsp;<br \/>NantKwest Inc. (USA)&nbsp;<br \/>Bristol-Myers Squibb (USA)&nbsp;<br \/>NKT Therapeutics (USA)<\/strong><\/p>\n<p><strong>Market Size Split by Type&nbsp;<br \/><\/strong>Mogamulizumab&nbsp;<br \/>Lorvotuzumab Mertansine&nbsp;<br \/>Others&nbsp;<br \/>Market Size Split by Application&nbsp;<br \/>Cancer&nbsp;<br \/>Cardiovascular Diseases&nbsp;<br \/>Others<\/p>\n<p><strong>Market size split by Region&nbsp;<br \/><\/strong>North America&nbsp;<br \/>United States&nbsp;<br \/>Canada&nbsp;<br \/>Mexico&nbsp;<br \/>Asia-Pacific&nbsp;<br \/>China&nbsp;<br \/>India&nbsp;<br \/>Japan&nbsp;<br \/>South Korea&nbsp;<br \/>Australia&nbsp;<br \/>Indonesia&nbsp;<br \/>Singapore&nbsp;<br \/>Malaysia&nbsp;<br \/>Philippines&nbsp;<br \/>Thailand&nbsp;<br \/>Vietnam&nbsp;<br \/>Europe&nbsp;<br \/>Germany&nbsp;<br \/>France&nbsp;<br \/>UK&nbsp;<br \/>Italy&nbsp;<br \/>Spain&nbsp;<br \/>Russia&nbsp;<br \/>Central &amp; South America&nbsp;<br \/>Brazil&nbsp;<br \/>Rest of Central &amp; South America&nbsp;<br \/>Middle East &amp; Africa&nbsp;<br \/>GCC Countries&nbsp;<br \/>Turkey&nbsp;<br \/>Egypt&nbsp;<br \/>South Africa<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Complete Report Details <\/strong><strong>@ <a rel=\"nofollow\" href=\"https:\/\/www.wiseguyreports.com\/reports\/3444216-global-nk-cell-therapy-market-insights-forecast-to-2025\">https:\/\/www.wiseguyreports.com\/reports\/3444216-global-nk-cell-therapy-market-insights-forecast-to-2025<\/a><\/strong><\/p>\n<p><strong>&nbsp;<\/strong><\/p>\n<p><strong>Table of Contents -Major Key Points <\/strong><\/p>\n<p><strong>1 Study Coverage&nbsp;<br \/><\/strong>1.1 NK Cell Therapy Product&nbsp;<br \/>1.2 Key Market Segments&nbsp;<br \/>1.3 Key Manufacturers Covered&nbsp;<br \/>1.4 Market by Type&nbsp;<br \/>1.4.1 Global NK Cell Therapy Market Size Growth Rate by Type&nbsp;<br \/>1.4.2 Mogamulizumab&nbsp;<br \/>1.4.3 Lorvotuzumab Mertansine&nbsp;<br \/>1.4.4 Others&nbsp;<br \/>1.5 Market by Application&nbsp;<br \/>1.5.1 Global NK Cell Therapy Market Size Growth Rate by Application&nbsp;<br \/>1.5.2 Cancer&nbsp;<br \/>1.5.3 Cardiovascular Diseases&nbsp;<br \/>1.5.4 Others&nbsp;<br \/>1.6 Study Objectives&nbsp;<br \/>1.7 Years Considered<\/p>\n<p><strong>&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;<\/strong><\/p>\n<p><strong>11 Company Profiles&nbsp;<br \/><\/strong>11.1 Chipscreen Biosciences (China)&nbsp;<br \/>11.1.1 Chipscreen Biosciences (China) Company Details&nbsp;<br \/>11.1.2 Company Description&nbsp;<br \/>11.1.3 Sales, Revenue and Gross Margin of NK Cell Therapy&nbsp;<br \/>11.1.4 NK Cell Therapy Product Description&nbsp;<br \/>11.1.5 Recent Development&nbsp;<br \/>11.2 Affimed NV (Netherlands)&nbsp;<br \/>11.2.1 Affimed NV (Netherlands) Company Details&nbsp;<br \/>11.2.2 Company Description&nbsp;<br \/>11.2.3 Sales, Revenue and Gross Margin of NK Cell Therapy&nbsp;<br \/>11.2.4 NK Cell Therapy Product Description&nbsp;<br \/>11.2.5 Recent Development&nbsp;<br \/>11.3 Altor BioScience Corporation (USA)&nbsp;<br \/>11.3.1 Altor BioScience Corporation (USA) Company Details&nbsp;<br \/>11.3.2 Company Description&nbsp;<br \/>11.3.3 Sales, Revenue and Gross Margin of NK Cell Therapy&nbsp;<br \/>11.3.4 NK Cell Therapy Product Description&nbsp;<br \/>11.3.5 Recent Development&nbsp;<br \/>11.4 Innate Pharma SA (France)&nbsp;<br \/>11.4.1 Innate Pharma SA (France) Company Details&nbsp;<br \/>11.4.2 Company Description&nbsp;<br \/>11.4.3 Sales, Revenue and Gross Margin of NK Cell Therapy&nbsp;<br \/>11.4.4 NK Cell Therapy Product Description&nbsp;<br \/>11.4.5 Recent Development&nbsp;<br \/>11.5 Takeda Pharmaceutical (Japan)&nbsp;<br \/>11.5.1 Takeda Pharmaceutical (Japan) Company Details&nbsp;<br \/>11.5.2 Company Description&nbsp;<br \/>11.5.3 Sales, Revenue and Gross Margin of NK Cell Therapy&nbsp;<br \/>11.5.4 NK Cell Therapy Product Description&nbsp;<br \/>11.5.5 Recent Development&nbsp;<br \/>11.6 Sorrento Therapeutics Inc. (USA)&nbsp;<br \/>11.6.1 Sorrento Therapeutics Inc. (USA) Company Details&nbsp;<br \/>11.6.2 Company Description&nbsp;<br \/>11.6.3 Sales, Revenue and Gross Margin of NK Cell Therapy&nbsp;<br \/>11.6.4 NK Cell Therapy Product Description&nbsp;<br \/>11.6.5 Recent Development&nbsp;<br \/>11.7 NantKwest Inc. (USA)&nbsp;<br \/>11.7.1 NantKwest Inc. (USA) Company Details&nbsp;<br \/>11.7.2 Company Description&nbsp;<br \/>11.7.3 Sales, Revenue and Gross Margin of NK Cell Therapy&nbsp;<br \/>11.7.4 NK Cell Therapy Product Description&nbsp;<br \/>11.7.5 Recent Development&nbsp;<br \/>11.8 Bristol-Myers Squibb (USA)&nbsp;<br \/>11.8.1 Bristol-Myers Squibb (USA) Company Details&nbsp;<br \/>11.8.2 Company Description&nbsp;<br \/>11.8.3 Sales, Revenue and Gross Margin of NK Cell Therapy&nbsp;<br \/>11.8.4 NK Cell Therapy Product Description&nbsp;<br \/>11.8.5 Recent Development&nbsp;<\/p>\n<p><strong>&hellip;&hellip;&hellip;..CONTINUED<\/strong><\/p>\n<p><strong>&nbsp;<\/strong><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> Wiseguyreports.com<br \/><strong>Contact Person:<\/strong> Norah Trent<br \/><strong>Email:<\/strong> <a href='http:\/\/www.universalpressrelease.com\/?pr=nk-cell-therapy-market-2018-global-share-trend-segmentation-and-forecast-to-2025&#038;type=pra'>Send Email<\/a><br \/><strong>Phone:<\/strong> +1 646 845 9349, +44 208 133 9349<br \/><strong>City:<\/strong> Pune<br \/><strong>State:<\/strong> Maharashtra<br \/><strong>Country:<\/strong> India<br \/><strong>Website:<\/strong> <a href=\"http:\/\/www.wiseguyreports.com\" target=\"_blank\" rel=\"nofollow\">www.wiseguyreports.com<\/a><\/p>\n<p><object type=\"text\/html\" data=\"http:\/\/www.wiseguyreports.com\" style=\"width:605px; height:400px;\"><\/object><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=nk-cell-therapy-market-2018-global-share-trend-segmentation-and-forecast-to-2025\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;\\&#8221;NK Cell Therapy Market\\&#8221;&#8221; Wiseguyreports.Com Added New Market Research Report On -\u201cGlobal NK Cell Therapy Market 2018 Top Key Players, Production , Growth and Future Demand Forecast to 2025 \u201d. &nbsp; &nbsp; Global NK Cell Therapy Market WiseGuyRerports.com Presents &ldquo;Global &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/nk-cell-therapy-market-2018-global-share-trend-segmentation-and-forecast-to-2025_284174.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-284174","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/284174","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=284174"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/284174\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=284174"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=284174"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=284174"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}